📅 Tuesday 4 March 2025
⏰ 12:00 – 13:00 CET
Spend your lunch break with us and learn more about IL-1 and its role in Kawasaki disease. This session will bring together leading experts to explore the its basic and clinical implications. Whether you’re a clinician, researcher, or simply interested in the science behind inflammation, this discussion will offer valuable insights into IL-1’s impact on disease progression and treatment.
Expert Speakers
Pr. Isabelle Kone-Paut (Kremlin-Bicêtre Hospital, University of Paris Sud-Saclay)
A leading expert in paediatric rheumatology, Pr. Kone-Paut has dedicated her career to improving care for children with inflammatory rheumatic diseases. Her team, which follows over 300 autoinflammatory patients annually, developed AIDAI, the first disease activity score for autoinflammatory conditions. With over 30 clinical trials and leadership roles in EUROFEVER and IMMUNAID, she brings extensive expertise to the discussion.
Dr. Christoph Kessel (University Children’s Hospital, Muenster, Germany)
Head of the Translational Inflammation Research Unit, Dr. Kessel focuses on understanding biochemical and cellular inflammatory mechanisms. His research explores biomarkers and disease pathways, particularly in Still’s disease and related complications, translating scientific discoveries into clinical practice.
Session Chairs
Dr. Teresa Giani
Dr. Federica Anselmi (Kremlin-Bicêtre Hospital, Paris)
A paediatric rheumatologist specialising in autoimmune and autoinflammatory diseases, Dr. Anselmi has expertise in ultrasound, joint injections, and biotherapy management. She trained at CeRéMAIA in Paris and is actively involved in clinical trials, professional societies, and medical education.
Why Join?
- Gain expert insights into IL-1’s role in Kawasaki disease
- Hear from leading specialists in paediatric rheumatology
- Connect basic science with clinical applications
- Engage in a live discussion and ask your questions
Bring your lunch, tune in, and be part of the conversation!
